joint facility of the MHH and the Helmholtz Centre for Infection Research, and the Institute of Virology at the MHH. One project is concerned with the identification and characterisation of monoclonal
partner institutions, the spokesperson is Professor Dr. Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG). More information about RESIST can be
consortium, we have combined the necessary outstanding clinical, immunological, bioinformatics and virological expertise in the field of HDV from leading centres in Europe," emphasises Professor Dr Markus Cornberg
Dr. Daniel P. Depledge Medizinische Hochschule Hannover (Hannover Medical School) Institute of Virology, OE5230 Carl-Neuberg-Str. 1 30625 Hannover Phone +49 (0) 511 532 4310 Departmental Secretary +49 [...] viral infections. In 2019 he became an Assistant Professor at NYU before joining the Institute of Virology at the Hannover Medical School (MHH) in 2021 as a DZIF Associate Professor. Alumni of the Group
Students of the year 2003 Khaled Alkarsah SYRIA supervisor: Prof. Dr. Schulz, Virology, project: Viral and genetic determinants of KSHV/HHV8 transmission from mothers to children Final exam November 2006
Simon Krooss GERMANY supervisor: PD Dr. Michael Ott, Gastro-Hepa-Endo, OE 6810, Dr. Jens Bohne, Virology, OE 5230, project: Gene therapy of hereditary metabolic liver diseases by targeted genome editing
ns of the MHH laboratories Institute for Medical Microbiology and Hospital Hygiene Institute of Virology Institute of Immunology Institute for Laboratory Animal Science and Central Animal Laboratory Institute
partner institutions. The spokesperson is Professor Dr Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG). For further information, please visit
gy, OE 6810, Left program in December 2015! Rishikesh Lotke INDIA supervisor: Prof. Dr. Schulz, Virology, OE 5230, project: Does the latent replication of gammaherpesviral genomes occur in a particular
SARS-CoV-2 Project leader: Prof. Dr. med. Thomas F. Schulz Department / Institute: Institute of Virology We want to generate broadly neutralizing, i.e. protective, human monoclonal antibodies as recombinant [...] Project leader: Prof. Dr. Thomas Pietschmann Department / Institute: Institute of Experimental Virology - TWINCORE In recent years, three genetically and biologically different corona viruses have been